000165129 001__ 165129
000165129 005__ 20230915090606.0
000165129 0247_ $$2doi$$a10.3390/life12081164
000165129 0247_ $$2pmid$$apmid:36013343
000165129 0247_ $$2pmc$$apmc:PMC9410039
000165129 037__ $$aDZNE-2022-01436
000165129 041__ $$aEnglish
000165129 082__ $$a570
000165129 1001_ $$0P:(DE-2719)9001817$$aEhlting, Anne$$b0$$eFirst author$$udzne
000165129 245__ $$aImpact of Hypoxia-Ischemia on Neurogenesis and Structural and Functional Outcomes in a Mild-Moderate Neonatal Hypoxia-Ischemia Brain Injury Model.
000165129 260__ $$aBasel$$bMDPI$$c2022
000165129 3367_ $$2DRIVER$$aarticle
000165129 3367_ $$2DataCite$$aOutput Types/Journal article
000165129 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1664543395_12114
000165129 3367_ $$2BibTeX$$aARTICLE
000165129 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000165129 3367_ $$00$$2EndNote$$aJournal Article
000165129 500__ $$aCC BY: https://creativecommons.org/licenses/by/4.0/
000165129 520__ $$aHypoxic-ischemic encephalopathy (HIE) is a common type of brain injury caused by a lack of oxygen and blood flow to the brain during the perinatal period. The incidence of HIE is approximately 2-3 cases per 1000 live births in high-income settings; while in low- and middle-income countries, the incidence is 3-10-fold higher. Therapeutic hypothermia (TH) is the current standard treatment for neonates affected by moderate-severe HIE. However, more than 50% of all infants with suspected HIE have mild encephalopathy, and these infants are not treated with TH because of their lower risk of adverse outcomes. Despite this, several analyses of pooled data provide increasing evidence that infants who initially have mild encephalopathy may present signs of more significant brain injury later in life. The purpose of this study was to expand our knowledge about the effect of mild-moderate hypoxia-ischemia (HI) at the cellular, structural, and functional levels. An established rat model of mild-moderate HI was used, where postnatal day (P) 7 rats were exposed to unilateral permanent occlusion of the left carotid artery and 90 min of 8% hypoxia, followed by TH or normothermia (NT) treatment. The extent of injury was assessed using histology (P14 and P42) and MRI (P11 and P32), as well as with short-term and long-term behavioral tests. Neurogenesis was assessed by BrdU staining. We showed that mild-moderate HI leads to a progressive loss of brain tissue, pathological changes in MRI scans, as well as an impairment of long-term motor function. At P14, the median area loss assessed by histology for HI animals was 20% (p < 0.05), corresponding to mild-moderate brain injury, increasing to 55% (p < 0.05) at P42. The data assessed by MRI corroborated our results. HI led to a decrease in neurogenesis, especially in the hippocampus and the lateral ventricle at early time points, with a delayed partial recovery. TH was not neuroprotective at early time points following mild-moderate HI, but prevented the increase in brain damage over time. Additionally, rats treated with TH showed better long-term motor function. Altogether, our results bring more light to the understanding of pathophysiology following mild-moderate HI. We showed that, in the context of mild-moderate HI, TH failed to be significantly neuroprotective. However, animals treated with TH showed a significant improvement in motor, but not cognitive long-term function. These results are in line with what is observed in some cases where neonates with mild HIE are at risk of neurodevelopmental deficits in infancy or childhood. Whether TH should be used as a preventive treatment to reduce adverse outcomes in mild-HIE remains of active interest, and more research has to be carried out in order to address this question.
000165129 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000165129 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000165129 650_7 $$2Other$$aBrdU
000165129 650_7 $$2Other$$aMRI
000165129 650_7 $$2Other$$abehavior testing
000165129 650_7 $$2Other$$ahypothermia
000165129 650_7 $$2Other$$ahypoxia-ischemia
000165129 650_7 $$2Other$$amild HIE
000165129 650_7 $$2Other$$aneonatal
000165129 650_7 $$2Other$$aneurogenesis
000165129 7001_ $$0P:(DE-2719)9000835$$aZweyer, Margit$$b1$$udzne
000165129 7001_ $$0P:(DE-2719)9001055$$aMaes, Elke$$b2$$udzne
000165129 7001_ $$0P:(DE-2719)2811751$$aSchleehuber, Yvonne$$b3$$udzne
000165129 7001_ $$0P:(DE-2719)2814350$$aDoshi, Hardik$$b4$$udzne
000165129 7001_ $$0P:(DE-2719)9000732$$aSabir, Hemmen$$b5$$udzne
000165129 7001_ $$0P:(DE-2719)2810557$$aBernis, Maria Eugenia$$b6$$eLast author$$udzne
000165129 770__ $$aDiversifying and Strengthening Translational Animal Models of Newborn Brain Injuries
000165129 773__ $$0PERI:(DE-600)2662250-6$$a10.3390/life12081164$$gVol. 12, no. 8, p. 1164 -$$n8$$p1164$$tLife$$v12$$x2075-1729$$y2022
000165129 8564_ $$uhttps://pub.dzne.de/record/165129/files/DZNE-2022-01436.pdf$$yOpenAccess
000165129 8564_ $$uhttps://pub.dzne.de/record/165129/files/DZNE-2022-01436.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000165129 909CO $$ooai:pub.dzne.de:165129$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000165129 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001817$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000165129 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000835$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000165129 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001055$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000165129 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811751$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000165129 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2814350$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b4$$kDZNE
000165129 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000732$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000165129 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810557$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000165129 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000165129 9141_ $$y2022
000165129 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-08-22
000165129 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-08-22
000165129 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-08-22
000165129 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-08-22
000165129 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000165129 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000165129 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2020-08-22
000165129 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLIFE-BASEL : 2021$$d2023-03-30
000165129 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-03-30
000165129 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-03-30
000165129 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2022-08-24T10:50:14Z
000165129 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2022-08-24T10:50:14Z
000165129 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2022-08-24T10:50:14Z
000165129 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-03-30
000165129 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-03-30
000165129 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-03-30
000165129 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-03-30
000165129 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-03-30
000165129 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-03-30
000165129 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-03-30
000165129 9201_ $$0I:(DE-2719)5000032$$kAG Sabir$$lNeonatal Neuroscience$$x0
000165129 9201_ $$0I:(DE-2719)1040270$$kSAMRI$$lSmall Animal MRI (SAMRI)$$x1
000165129 980__ $$ajournal
000165129 980__ $$aVDB
000165129 980__ $$aUNRESTRICTED
000165129 980__ $$aI:(DE-2719)5000032
000165129 980__ $$aI:(DE-2719)1040270
000165129 9801_ $$aFullTexts